Literature DB >> 18690539

Nonclassic adrenal hyperplasia.

Phyllis W Speiser1.   

Abstract

Nonclassic adrenal hyperplasia is most commonly attributable to mutations in CYP21A2 (also termed CYP21) encoding steroid 21-hydroxylase. Partial deficiency of this enzyme causes an imbalance in cortisol synthesis with consequent adrenal androgen excess. Unlike more severe forms of congenital adrenal hyperplasia, this condition is rarely recognized in infants, but rather is a potential cause of premature adrenarche and pubarche in children, virilization in young women, and variable symptoms in young men. This article will review relevant clinical, hormonal and genetic aspects of nonclassic adrenal hyperplasia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18690539     DOI: 10.1007/s11154-008-9097-x

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  23 in total

Review 1.  Clinical practice. Hirsutism.

Authors:  Robert L Rosenfield
Journal:  N Engl J Med       Date:  2005-12-15       Impact factor: 91.245

2.  High frequency of nonclassical steroid 21-hydroxylase deficiency.

Authors:  P W Speiser; B Dupont; P Rubinstein; A Piazza; A Kastelan; M I New
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

Review 3.  Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society.

Authors:  P B Kaplowitz; S E Oberfield
Journal:  Pediatrics       Date:  1999-10       Impact factor: 7.124

4.  Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia.

Authors:  C Moran; R Azziz; N Weintrob; S F Witchel; V Rohmer; D Dewailly; J A M Marcondes; M Pugeat; P W Speiser; D Pignatelli; B B Mendonca; T A S Bachega; H F Escobar-Morreale; E Carmina; F Fruzzetti; F Kelestimur
Journal:  J Clin Endocrinol Metab       Date:  2006-07-05       Impact factor: 5.958

5.  Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia.

Authors:  J Fitness; N Dixit; D Webster; T Torresani; R Pergolizzi; P W Speiser; D J Day
Journal:  J Clin Endocrinol Metab       Date:  1999-03       Impact factor: 5.958

6.  Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia.

Authors:  Felix Votava; Dóra Török; József Kovács; Dorothea Möslinger; Sabina M Baumgartner-Parzer; János Sólyom; Zuzana Pribilincová; Tadej Battelino; Jan Lebl; Herwig Frisch; Franz Waldhauser
Journal:  Eur J Endocrinol       Date:  2005-06       Impact factor: 6.664

7.  Development of cortisol circadian rhythm in infancy.

Authors:  Carolina de Weerth; Robbert H Zijl; Jan K Buitelaar
Journal:  Early Hum Dev       Date:  2003-08       Impact factor: 2.079

8.  Androgen excess in women: experience with over 1000 consecutive patients.

Authors:  R Azziz; L A Sanchez; E S Knochenhauer; C Moran; J Lazenby; K C Stephens; K Taylor; L R Boots
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

9.  Isolated precocious pubarche: an approach.

Authors:  R Balducci; B Boscherini; A Mangiantini; M Morellini; V Toscano
Journal:  J Clin Endocrinol Metab       Date:  1994-08       Impact factor: 5.958

10.  Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency.

Authors:  Chantal Lutfallah; Weihua Wang; J Ian Mason; Ying Tai Chang; Anzar Haider; Barry Rich; Mariano Castro-Magana; Kenneth C Copeland; Raphael David; Songya Pang
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

View more
  12 in total

1.  The clinical and biochemical spectrum of congenital adrenal hyperplasia secondary to 21-hydroxylase deficiency.

Authors:  Tony Huynh; Ivan McGown; David Cowley; Ohn Nyunt; Gary M Leong; Mark Harris; Andrew M Cotterill
Journal:  Clin Biochem Rev       Date:  2009-05

Review 2.  Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): an update.

Authors:  Christine M Trapp; Sharon E Oberfield
Journal:  Steroids       Date:  2011-12-13       Impact factor: 2.668

3.  A sequence variation in 3'UTR of CYP21A2 gene correlates with a mild form of congenital adrenal hyperplasia.

Authors:  S Menabò; A Balsamo; L Baldazzi; M Barbaro; A Nicoletti; V Conti; P Pirazzoli; A Wedell; A Cicognani
Journal:  J Endocrinol Invest       Date:  2011-04-26       Impact factor: 4.256

4.  Ashwagandha root in the treatment of non-classical adrenal hyperplasia.

Authors:  Amir Kalani; Gul Bahtiyar; Alan Sacerdote
Journal:  BMJ Case Rep       Date:  2012-09-17

5.  Roux-en-Y gastric bypass in the treatment of non-classic congenital adrenal hyperplasia due to 11-hydroxylase deficiency.

Authors:  Amir Kalani; Nithin Thomas; Alan Sacerdote; Gül Bahtiyar
Journal:  BMJ Case Rep       Date:  2013-03-18

6.  Genotype-phenotype correlation in 27 pediatric patients in congenital adrenal hyperplasia due to 21-hydroxylase deficiency in a single center.

Authors:  Yangho Yoo; Mi Sun Chang; Jieun Lee; Sung Yoon Cho; Sung Won Park; Dong-Kyu Jin; Hyung-Doo Park
Journal:  Ann Pediatr Endocrinol Metab       Date:  2013-09-30

7.  A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form.

Authors:  Paola Concolino; Enrica Mello; Angelo Minucci; Emiliano Giardina; Cecilia Zuppi; Vincenzo Toscano; Ettore Capoluongo
Journal:  BMC Med Genet       Date:  2009-07-22       Impact factor: 2.103

8.  Growth hormone deficiency with advanced bone age: phenotypic interaction between GHRH receptor and CYP21A2 mutations diagnosed by sanger and whole exome sequencing.

Authors:  Fernanda A Correa; Marcela M França; Qing Fang; Qianyi Ma; Tania A Bachega; Andresa Rodrigues; Bilge A Ozel; Jun Z Li; Berenice B Mendonca; Alexander A L Jorge; Luciani R Carvalho; Sally A Camper; Ivo J P Arnhold
Journal:  Arch Endocrinol Metab       Date:  2017-12       Impact factor: 2.309

9.  Prevalence of nonclassic congenital adrenal hyperplasia in Turkish children presenting with premature pubarche, hirsutism, or oligomenorrhoea.

Authors:  Cigdem Binay; Enver Simsek; Oguz Cilingir; Zafer Yuksel; Ozden Kutlay; Sevilhan Artan
Journal:  Int J Endocrinol       Date:  2014-03-23       Impact factor: 3.257

10.  Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study.

Authors:  Atsumi Tsuji; Kaoru Konishi; Satomi Hasegawa; Akira Anazawa; Toshikazu Onishi; Makoto Ono; Tomohiro Morio; Teruo Kitagawa; Kenichi Kashimada
Journal:  BMC Pediatr       Date:  2015-12-15       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.